Our long range goal is to contribute to an understanding of the biochemical mechanisms underlying the regulation of eukaryotic messenger RNA synthesis. The major goal of the research described in this proposal is to determine, at the molecular level, how promoter-specific transcription by RNA polymerase II (Pol II) is controlled by the action of a set of transcription factors that direct accurate initiation and efficient elongation of transcripts in vitro. Our overall approach is essentially the same as that described in the previous proposals: (i) to reconstitute in vitro, with purified proteins, faithful and efficient transcription of eukaryotic protein-coding genes and (ii) to use this reconstituted system to elucidate the biochemical mechanisms governing transcription initiation and elongation by mammalian Pol II. This research will be organized along the following lines: (1) Further analysis of the mechanism of action of Pol II elongation factor Elongin A and of its newly described role in UV-induced ubiquitination of Pol II. (2) Further investigation of the mechanism of action of Pol II elongation factor ELL. (3) Detailed analysis of the mechanisms of action of two novel human ATP-dependent chromatin remodelers referred to as the human INO80 complex and the SNF2 family member and oncogene ALC1 (Activated in Liver Cancer 1). These studies should provide information on the basic mechanisms governing eukaryotic messenger RNA synthesis, and they also have the potential to yield new insights into the molecular bases of cancers resulting from abherrant expression of ELL and its associated proteins and of ALC1.

Public Health Relevance

It is well established that eukaryotic messenger RNA synthesis is a major site for the regulation of gene expression and, further, that its misregulation often results in human diseases, including many forms of cancer. Eukaryotic messenger RNA synthesis is a complex biochemical process catalyzed by the enzyme RNA polymerase II with the assistance of a diverse collection of transcription factors. Despite considerable progress over the past 20 years, critical aspects of the mechanisms underlying misregulation of eukaryotic messenger RNA synthesis in human disease are not completely understood. As a consequence, the goal of the research described in this proposal is to contribute to an understanding of the biochemical mechanisms underlying the regulation of messenger RNA synthesis in mammalian cells. In particular, we plan to pursue investigations of the mechanisms of action of several transcription factors discovered in our lab. In addition to shedding light on the basic mechanisms governing mammalian messenger RNA synthesis, these studies have the potential to shed light on aspects of cancer, since two transcription factors, ELL and ALC1, which we plan to investigate have been proposed to participate in the etiology of acute myeloid leukemia and hepatocellular carcinoma, respectively.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Molecular Genetics A Study Section (MGA)
Program Officer
Sledjeski, Darren D
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Stowers Institute for Medical Research
Kansas City
United States
Zip Code
Tsai, Kuang-Lei; Tomomori-Sato, Chieri; Sato, Shigeo et al. (2014) Subunit architecture and functional modular rearrangements of the transcriptional mediator complex. Cell 157:1430-44
Tsai, Kuang-Lei; Sato, Shigeo; Tomomori-Sato, Chieri et al. (2013) A conserved Mediator-CDK8 kinase module association regulates Mediator-RNA polymerase II interaction. Nat Struct Mol Biol 20:611-9
Tomomori-Sato, Chieri; Sato, Shigeo; Conaway, Ronald C et al. (2013) Immunoaffinity purification of protein complexes from Mammalian cells. Methods Mol Biol 977:273-87
Conaway, Ronald C; Conaway, Joan Weliky (2013) The Mediator complex and transcription elongation. Biochim Biophys Acta 1829:69-75
Sela, Dotan; Conkright, Juliana J; Chen, Lu et al. (2013) Role for human mediator subunit MED25 in recruitment of mediator to promoters by endoplasmic reticulum stress-responsive transcription factor ATF6*. J Biol Chem 288:26179-87
Zhao, Xiaoming; Su, Jiaming; Wang, Fei et al. (2013) Crosstalk between NSL histone acetyltransferase and MLL/SET complexes: NSL complex functions in promoting histone H3K4 di-methylation activity by MLL/SET complexes. PLoS Genet 9:e1003940
Conaway, Ronald C; Conaway, Joan Weliky (2011) Function and regulation of the Mediator complex. Curr Opin Genet Dev 21:225-30
Conaway, Ronald C; Conaway, Joan Weliky (2011) Origins and activity of the Mediator complex. Semin Cell Dev Biol 22:729-34
Chen, Lu; Cai, Yong; Jin, Jingji et al. (2011) Subunit organization of the human INO80 chromatin remodeling complex: an evolutionarily conserved core complex catalyzes ATP-dependent nucleosome remodeling. J Biol Chem 286:11283-9
Takahashi, Hidehisa; Parmely, Tari J; Sato, Shigeo et al. (2011) Human mediator subunit MED26 functions as a docking site for transcription elongation factors. Cell 146:92-104

Showing the most recent 10 out of 71 publications